Peer-reviewed veterinary case report
Proposal of metagenomic-origin LRA-5 as a precursor of active β-lactamases through Tyr69Gln and Val166Glu amino acid substitutions: a functional and structural analysis.
- Year:
- 2026
- Authors:
- D'Amico González G et al.
- Affiliation:
- Facultad de Farmacia y Bioquímica
- Species:
- cat
Abstract
Wild-type LRA-5, recovered from Alaskan soil samples, shares no more than 33% amino acid sequence identity with enzymes from pathogens like PER β-lactamases. Recombinant <i>E. coli</i> expressing wild-type LRA-5 and its engineered variants LRA-5<sup>Y69Q</sup> and LRA-5<sup>V166E</sup> showed MIC values equivalent to control strains. However, LRA-5<sup>Y69Q/V166E</sup> displayed MICs above the resistant breakpoint for some β-lactams. Kinetic parameters correlated with the MICs, showing that the catalytic efficiency of LRA-5<sup>Y69Q/V166E</sup> was comparable to those from class A β-lactamases, such as CTX-M-15, PER-2, and KPC-2. LRA-5<sup>Y69Q/V166E</sup> exhibited <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> values up to 11,000-fold higher compared to wild-type LRA-5, which is associated with the presence of Glu166. The X-ray crystallographic structure of wild-type LRA-5 (1.80 Å; PDB 8EO5) shows that the lack of both Glu166 and a deacylation water molecule contributes to a biologically insignificant activity. Interactions observed between LRA-5 and ceftazidime (2.35 Å; PDB 8EO6) show structural conservation with other β-lactamases. In contrast, the crystallographic structure of LRA-5<sup>Y69Q/V166E</sup> (2.15 Å; PDB 8EO7) bears a deacylation water molecule that is associated with the increase in catalytic activity compared to the wild-type variant. Circular dichroism results confirm that amino acid substitutions in LRA-5 do not affect the overall content of the secondary/tertiary structures. Evidence suggests that alternative evolutionary paths could have occurred for β-lactamases like LRA-5, produced by environmental microorganisms: (i) proteins having similar structural features than active β-lactamases may accumulate a small number of mutations (e.g., Y69Q/V166E) to yield active enzymes and (ii) the β-lactamase fold may have lost key residues in the absence of antibiotics.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://europepmc.org/article/MED/41312992